AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 82 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2020. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $73,505,075 | -34.5% | 7,136,415 | +4.8% | 1.55% | -27.4% |
Q2 2023 | $112,239,364 | +113.4% | 6,810,641 | +18.6% | 2.14% | +95.2% |
Q1 2023 | $52,596,161 | +27.9% | 5,741,939 | 0.0% | 1.10% | +30.5% |
Q4 2022 | $41,112,283 | +42.9% | 5,741,939 | 0.0% | 0.84% | +26.5% |
Q3 2022 | $28,767,000 | +105.3% | 5,741,939 | 0.0% | 0.66% | +83.1% |
Q2 2022 | $14,010,000 | -64.3% | 5,741,939 | 0.0% | 0.36% | -55.4% |
Q1 2022 | $39,217,000 | -15.5% | 5,741,939 | 0.0% | 0.81% | +19.9% |
Q4 2021 | $46,395,000 | -17.6% | 5,741,939 | 0.0% | 0.68% | -20.3% |
Q3 2021 | $56,271,000 | +45.6% | 5,741,939 | 0.0% | 0.85% | +45.6% |
Q2 2021 | $38,643,000 | -25.6% | 5,741,939 | 0.0% | 0.58% | -28.0% |
Q1 2021 | $51,907,000 | +44.2% | 5,741,939 | +6.6% | 0.81% | +34.1% |
Q4 2020 | $35,989,000 | +33.1% | 5,387,513 | +0.4% | 0.60% | -7.2% |
Q3 2020 | $27,048,000 | -36.9% | 5,366,705 | +1.1% | 0.65% | -46.0% |
Q2 2020 | $42,877,000 | +18.3% | 5,306,570 | +14.9% | 1.21% | -22.7% |
Q1 2020 | $36,253,000 | +41.2% | 4,616,570 | +35.7% | 1.56% | +61.1% |
Q4 2019 | $25,681,000 | – | 3,401,434 | – | 0.97% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |